23 Clinical Lab Tests
-
Upload
dr-muhammad-junaid-hassan-sharif -
Category
Documents
-
view
17 -
download
6
description
Transcript of 23 Clinical Lab Tests
-
Physical Evaluation of the Dental PatientDr. Nelson L. RhodusDiplomate, American Board of Oral MedicineMorse Alumni Distinguished ProfessorDirector of Oral MedicineUniversity of Minnesota
-
Clinical laboratory testingRelevant to dentistryIndicationsSigns and symptoms of diseaseHigh risk groupsConfirm clinical diagnosisCategories of lab testsDiagnosticScreening
-
THE DIAGNOSTIC PROCESS
-
Clinical laboratory testingLab tests used frequently by DDS
CBC( complete blood count)HemoglobinHematocritRBC, WBCDifferential WBC
-
Clinical laboratory testingLab tests used frequently by DDS
Bleeding studiesPT( INR): Prothrombin TimePTT ( INR): Partial Thromboplastin TimeBT: Bleeding timePlatelet count
-
Clinical laboratory testingLab tests used frequently by DDSFasting blood glucose( 126 mg %)Hb A 1 C
Infectious diseases:HBV, HCV, HIV, other
-
Clinical laboratory testingLab tests used frequently by DDS
DDS should have a working concept of WNL( range)Errors in testingClinical scenario MOST IMPORTANT!May need to repeat test in light of clinical impression
-
Clinical laboratory testingLab tests used frequently by DDSCBC : RBC4.6 - 6.2 million /cc- male4.2 - 5.4 million/cc- femaleErythrocytopenia=Decrease= AnemiasFe, B-12, folate, pernicious, sickle cellErythrocytosis= Increase= Polycythemia dehydration, infection-fever
-
Clinical laboratory testingLab tests used frequently by DDSCBC : Hemoglobin ( Hb)Oxygen-carrying capacity13.5- 18.0 g/100cc- males11.5- 16.4 g/100cc - females
-
Clinical laboratory testingLab tests used frequently by DDSCBC : Hematocrit ( Hct)Volume of RBCs per 100 cc of blood40 - 52 %- males35- 47 %- females
-
Clinical laboratory testingLab tests used frequently by DDSCBC : mean corpuscular hemoglobin( MCH)Average Hb content of each RBC 27-32 pg
-
Clinical laboratory testingLab tests used frequently by DDSCBC : erythrocyte sedimentation rate ( ESR)= aggregated RBCsWNL < 20 mm/hr.InflammationIncrease= tissue destruction
-
Clinical laboratory testingLab tests used frequently by DDSCBC : WBC5,000 - 10,000 / ccLeukocytosis= increased WBC infection, RF, allergies, necrosis, exercise, pregnancy, stress, drugs, LEUKEMIALeukopenia= decreased WBChypovolemia, early leukemia, drugs, radiation, blood dyscrasias
-
Clinical laboratory testingLab tests used frequently by DDSCBC : differential WBCNeutrophils( segmented) = 50-70% Neutrophils( band) = 0- 5%Lymphocytes=25-40%Monocytes= 4-8%Eosinophils= 1- 4%Basophils= 0- 1%
-
Clinical laboratory testingLab tests used frequently by DDSCBC : differential WBCLEUKEMIASAcute lymphocytic( lymphoblastic) leukemiaAcute myelogenous leukemiaChronic lymphocytic( lymphoblastic) leukemiaChronic myelogenous leukemia
-
Clinical laboratory testingLab tests used frequently by DDSCBC : differential WBCLYMPHOMASHodgkins, non- Hodgkins, Burkitts
-
Clinical laboratory testingNeutrophilic leukocytosis: bacterial infections, inflammatory disorders, drug reactions, leukemiaLymphocytosis: bacterial infections, viral infections, leukemiaEosinophilic leukocytosis: allergic reactions
-
Clinical laboratory testingBLOOD CHEMISTRYSMA-12/60
-
Clinical laboratory testingBLOOD CHEMISTRYBONE METABOLISMCalcium, Phosphorous, Alkaline phosphatase
-
Clinical laboratory testingBLOOD CHEMISTRYBONE METABOLISMCalcium, Phosphorous, Alkaline phosphataseHyperparathyroidism, Multiple myelomaPagets disease, fibrous dysplasiaOsteoporosis , Cancer
-
Clinical laboratory testingBLOOD CHEMISTRYBONE METABOLISMCalcium9.0-10.5 mg%Hypocalcemia: hypoparathyroidism, Vit. D deficicency, preganancy, diuretics
-
Clinical laboratory testingBLOOD CHEMISTRYBONE METABOLISMPhosphorus3.0- 4.5 mg%Hyperphosphatemia: hypoparathyroidism, renal disease, hyperthyroidism, hypervitaminoisis DHypophosphatemia: hyperparathyroidism, malabsorption, Vit. D deficiency
-
Clinical laboratory testingBLOOD CHEMISTRYBONE METABOLISMAlkaline phosphatase25 - 115 Units/LElevated: hyperparathyroidism, Pagets, sarcomas, metastatic carcinoma, growth
-
Clinical laboratory testingBLOOD CHEMISTRYRENAL FUNCTION TESTSBUN ( blood urea nitrogen)Uric AcidCreatinine
-
Clinical laboratory testingBLOOD CHEMISTRYRENAL FUNCTION TESTSBUN ( blood urea nitrogen)8-18 mg%Uric acid2.4-7.5 mg %Increased: Chronic renal failure, chemo-Tx, lymphoproliferative disease, gout , acidosis
-
Clinical laboratory testingBLOOD CHEMISTRYRENAL FUNCTION TESTSCreatinine0.6-1.2 mg%Increased: Chronic renal failure, CHF, acromegaly, dehydration, diabetes, shock
-
Clinical laboratory testingBLOOD CHEMISTRYLIVER FUNCTION TESTSLDH: lactate dehydrogenaseAST: aspartate aminotransferaseALT: alanine aminotransferase( SGPT)Alkaline phosphataseBilirubin, Protein, Albumin
-
Clinical laboratory testingBLOOD CHEMISTRYLIVER FUNCTION TESTSLDH: lactate dehydrogenase50-240 Units/LALT0-40 Units/L
-
Clinical laboratory testingBLOOD CHEMISTRYLIVER FUNCTION TESTSLDH and ALT increased:MI, liver disease, mononucleosis, renal disease, anemia, pancreatitis, skeletal muscle damage
-
Clinical laboratory testingBLOOD CHEMISTRYLIVER FUNCTION TESTSBilirubin02.-1.5 mg %liver disease: hepatitis, cirrhosis, drug toxicities
-
Clinical laboratory testingBLOOD CHEMISTRYLIVER FUNCTION TESTSTotal protein5.6-8.4 g %Albumin= 3.4- 5.4 g %Globulins= 2.2-3.0 g %liver disease: cirrhosis, chronic infections,Multiple myeloma
-
Clinical laboratory testingBLOOD CHEMISTRYBLOOD GLUCOSE70-100 mg %Fasting > 126 mg % = diabetesIncreased : corticosteroids, catecholamines, growth hormone, CHF, diuretics
- Clinical laboratory testingBLOOD CHEMISTRYSERUM CHOLESTEROL
-
Normal control of bleedingVascular phasePlatelet phaseCoagulation phase
-
bleeding problemsInheritedAcquiredDrug therapy
-
Detection of the patient with bleeding problemsProthrombin time( PT ) or International Normalized Ratio (INR)Partial thromboplastin time (PTT)Thrombin time (TT)Bleeding time (BT)Platelet count
-
Prothrombin time (PT)activated by tissue thromboplastintests extrinsic and common pathwaysrun with a control ( variable with lab : therefore: INR)normal= 11-15 secondsprolonged time = abnormal ( significant for dentistry > 2.5, 3.0, 3.5...)
-
Activated partial thromboplastin time (PTT)Contact activator( kaolin)tests the intrinsic and common pathwaysrun with a controlnormal= 25-35 secondsprolonged ( 2.5, 3.0, 3.5...)= abnormal
-
Thrombin time(TT)activated by thrombintests the ability to form a solid clotrun with a controlnormal= 9-13 secondsprolonged( 2.5, 3.0, 3.5,...) = abnormal
-
Ivy bleeding time (IBT)tests vascular and platelet statusImmediate factors in control of bleedingnormal = 1-6 minutesabnormal = prolonged time
-
Platelet counttests numbers of platelets present to form clotnormal= 140,000 to 400,000 / ccbleeding problems < 50,000/cc
-
Thrombocytopeniaplatelet count ~ 50,000 ( with or without platelet replacement)< 50,000 = bleeding problem
-
Bleeding disordersNonthrombocytopenic purpurasvascular wall alterationsplatelet function disorderThrombocytopenic purpurasPrimary ( genetic)secondary( acquired: drugs, diseases)Disorders of coagulationinherited, acquired
-
Microbiological examSample collection ( bacterial, fungal, etc.)LesionTransport mediaClinical information: site, nature, differential diagnosisID organismAntimicrobial sensitivity : long-term Rx, diabetes, immunosuppressed, refractory to TxClosely follow course of TX
-
Diabetes mellitus Detection and managementDr. Nelson L. RhodusDirector of Oral MedicineUniversity of Minnesota
-
CytologyExfoliative cytology ( Oral CDx)= brush biopsy.. PAP smear
Scrape off surface of lesion to BM if possibleUseful for : HSV, Candidiasis, pemphigus, some bacteria, cellular atypia
-
Exfoliative cytologyOral CDx ( brush biopsy)some, limited clinical diagnostic value( decide to Bx)irregular epilthelial cells (not flat)enlarged, irregular size and shape of nucleihyperchromatic nuclei
-
ORAL CANCERDETECTIONCLINICAL vs. DEFINITIVE DIAGNOSISHISTOPATHOLOGY ..MUST !!lesion with MODERATE DEGREE of clinical suspicion ...BIOPSYlesion with HIGH DEGREE of clinical suspicion...REFER
-
Leukoplakia to SCCAmean age 63; F = M time to transformation = 7.2 yearsprecedent dysplasia= 17%17 % WITH Bx-proven dysplasia >>> SCCA in 3 yrs.
-
BiopsyExcisional- entire lesion is removedIncisional- portion of large lesionPunchFine-needle aspirationOral pathologistClinical information to pathologist
-
Toludine blueOra-scanbinds to DNA93 % accurate = adjunctuptake= high yield + marginsfalse + ves
-
Candida speciesseveral common species in oral cavityCandida may proliferate with immunosuppressionincrease in Candida counts with decreased salivary flowassociated with diabetes, hematologic abnormalities and several other disorders including Sjogrens syndrome
-
DiascopyDetects blood in a blisterform lesionPress on lesion with a glass microscope slideIf color blanches= blood-filledOxidized vs. reduced blood
-
FNAsalivary glandslymph nodes22 gauge needle + 10 - 20 ml syringecytology
-
Asdvanced laboratory techniquesDNA testing( microarray, RT-pcr, etc.)Cytogenetics, chromosomalViral testingELISA, enzyme assaysImmunofluorescenceAntibodiesSalivary scintigraphyMRI, CT , etc.
-
Candidiasis53% in SCCA ; 31 % in WNLchronic fungi : epithelial adhesionimmunoincompetencehigher correlation with leukoplakias to SCCA transformation (61%)